Andrew Perry, Chief Commercial Officer: G1 Therapeutics GTHX Sell · Filed 24/05/15

Trade details

Type: Insider sale
Amount: $39,043.29
Shares · price: 8,151 sh · $4.79 a share
Held after: 78,951 sh
Stock: G1 Therapeutics GTHX
Person: Andrew PerryChief Commercial Officer
Trade date: 24/05/13
Filed: 24/05/15
Days to filing: 2 days

Sold 9.4% of holdings

Share of holding sold: 9.4%

G1 Therapeutics trades, last 26 weeks

What else happened in G1 Therapeutics around then

Filed or reported within 30 days of the trade day · 24/04/13~24/06/12

Andrew Perry's recent trades

Andrew PerryChief Commercial Officer
SellG1 Therapeutics
Sell
G1 Therapeutics
GTHX
$3,356
1,337 sh
$3,356
Filed 24/07/08
Traded 24/07/05
Andrew PerryChief Commercial Officer
SellG1 Therapeutics
Sell
G1 Therapeutics
GTHX
$1,182
379 sh
$1,182
Filed 24/01/08
Traded 24/01/03
Andrew PerryChief Commercial Officer
SellG1 Therapeutics
Sell
G1 Therapeutics
GTHX
$6,346
2,034 sh
$6,346
Filed 24/01/08
Traded 24/01/03
Andrew PerryChief Commercial Officer
Sell10b5-1 planG1 Therapeutics
Sell10b5-1 plan
G1 Therapeutics
GTHX
$870
355 sh
$870
Filed 23/07/07
Traded 23/07/05
Andrew PerryChief Commercial Officer
SellG1 Therapeutics
Sell
G1 Therapeutics
GTHX
$4,576
820 sh
$4,576
Filed 23/01/05
Traded 23/01/04